Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment

Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / Ministério da Saúde. Instituto Nacional de Saúde. Maputo, Mozambique
Bicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, France
Bicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, France
Epicentre. Paris, PAR, France
Ministério da Saúde. Instituto Nacional de Saúde. Maputo, Mozambique
Epicentre. Paris, PAR, France
Bicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, France
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil
Bicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, France / University Paris Sud. Faculty of Pharmacy. Paris, France
Epicentre. Paris, PAR, France
Bicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, France

Keywords

Tuberculosis
HIV
Rifampin
Isoniazid

DeCS

Tuberculose
HIV
Rifampina
Isoniazida

Publisher

American Society for Microbiology

Citation

BHATT, Nilesh Balbhadra et al. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. Antimicrobial Agents and Chemotherapy, v.58, n.6, p.3182–3190, 2014.

DOI

10.1128/AAC.02379-13

ISSN

0066-4804

Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/10578

Type

Copyright

Open access

Collections

Share

Statistics

Metadata

Author

Affilliation